Primary CD30-Positive T-Cell Lymphoproliferative Disorder — knowledge graph · CancerIndex

Knowledge graph · Cancer

Primary CD30-Positive T-Cell Lymphoproliferative Disorder

molecular subtype

Identifier: CI-CAN-00006485
Entity page: /cancer/primary-cd30-positive-t-cell-lymphoproliferative-disorder ↗
Edges: 20

Neighbours: 7 drugs10 trials
Drawn: 17 of 17 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Primary CD30-Positive T-Cell Lymphoproliferative Disorder investigated in trials for …INVESTIGATED_IN_TRIALSderived7 of 7
→ investigated in trials for	Brentuximab Vedotinadc 5 trials (3 active) · roll-up of the cancer and its descendants	—	—	Primary CD30-Positive T-Cell Lymphoproliferative Disorder	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Bexarotenesmall molecule

Primary CD30-Positive T-Cell Lymphoproliferative Disorder studied in …STUDIED_INderived10 of 13show all (up to 200)
→ studied in	NCT03409432Phase 2 · completed Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 13 trials mapped (8 active)	—	—	Lymphomatoid Papulosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT07717580Phase 2 · not yet recruiting Efficacy and Safety of Brentuximab Vedotin Combined With Lisaftoclax in CD30+ Cutaneous T-cell Lymphoma (CTCL) · condition mapped ONTOLOGY_EXACT · 13 trials mapped (8 active)	—	—	Primary Cutaneous Anaplastic Large Cell Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01352520Phase 2 · active not recruiting SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP) · condition mapped ONTOLOGY_EXACT · 13 trials mapped (8 active)	—	—	Primary Cutaneous Anaplastic Large Cell Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06207812recruiting Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis · condition mapped ONTOLOGY_EXACT · 13 trials mapped (8 active)	—	—	Lymphomatoid Papulosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT01787409NA · active not recruiting Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency · condition mapped ONTOLOGY_EXACT · 13 trials mapped (8 active)	—	—	Primary Cutaneous Anaplastic Large Cell Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03602157Phase 1 · active not recruiting Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL · condition mapped ONTOLOGY_EXACT · 13 trials mapped (8 active)	—	—	Lymphomatoid Papulosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT05978141recruiting A Registry for People With T-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 13 trials mapped (8 active)	—	—	Primary Cutaneous Anaplastic Large Cell Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03587844Phase 2 · recruiting Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients · condition mapped ONTOLOGY_EXACT · 13 trials mapped (8 active)	—	—	Lymphomatoid Papulosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT02840747recruiting Tissue Repository: CTCL Collection Protocol · condition mapped ONTOLOGY_EXACT · 13 trials mapped (8 active)	—	—	Lymphomatoid Papulosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT05106192NA · withdrawn Triamcinolone Acetonide Injections in Primary Cutaneous Lymphoma Plaques With a Novel Needle-free Drug-delivery System. · condition mapped ONTOLOGY_EXACT · 13 trials mapped (8 active)	—	—	Lymphomatoid Papulosis	1	Observed	clinicaltrials	graph →